Richard Pulik - 20 Apr 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
CFO
Signature
/s/ Jo Chen, as Attorney-in-Fact for Richard Pulik
Issuer symbol
ROIV
Transactions as of
20 Apr 2023
Transactions value $
$0
Form type
4
Filing time
24 Apr 2023, 21:28:12 UTC
Previous filing
31 Mar 2023
Next filing
03 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +66,710 +30.1% $0.000000 288,418 20 Apr 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROIV Stock Option (Right to Buy) Award $0 +383,496 $0.000000 383,496 20 Apr 2023 Common Shares 383,496 $8.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of 66,710 restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2023. 1/4 of the RSUs service-vest twelve (12) months after the vesting commencement date; 1/16 of the RSUs service-vest fourteen (14) months after the vesting commencement date; and the balance of the RSUs service-vest in a series of eleven (11) successive equal quarterly installments measured from the date fourteen (14) months after the vesting commencement date, subject to the reporting person's Continuous Service through the applicable vesting date.
F2 Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2023. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.